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Abstract
Decidualizing endometrial stromal cells (EnSC) critically determine the maternal 
response to an implanting conceptus, triggering either menstruation-like disposal of 
low-fitness embryos or creating an environment that promotes further development. 
However, the mechanism that couples maternal recognition of low-quality embryos 
to tissue breakdown remains poorly understood. Recently, we demonstrated that suc-
cessful transition of the cycling endometrium to a pregnancy state requires selective 
elimination of pro-inflammatory senescent decidual cells by activated uterine natural 
killer (uNK) cells. Here we report that uNK cells express CD44, the canonical hya-
luronan (HA) receptor, and demonstrate that high molecular weight HA (HMWHA) 
inhibits uNK cell-mediated killing of senescent decidual cells. In contrast, low mo-
lecular weight HA (LMWHA) did not attenuate uNK cell activity in co-culture ex-
periments. Killing of senescent decidual cells by uNK cells was also inhibited upon 
exposure to medium conditioned by IVF embryos that failed to implant, but not suc-
cessful embryos. Embryo-mediated inhibition of uNK cell activity was reversed by 
recombinant hyaluronidase 2 (HYAL2), which hydrolyses HMWHA. We further 
report a correlation between the levels of HYAL2 secretion by human blastocysts, 
morphological scores, and implantation potential. Taken together, the data suggest 
a pivotal role for uNK cells in embryo biosensing and endometrial fate decisions at 
implantation.
K E Y W O R D S
decidualization, embryo implantation, endometrium, hyaluronan, senescence, uterine natural killer 
cells
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1 |  INTRODUCTION
The midluteal window of implantation constitutes an inflec-
tion point in the menstrual cycle, after which the endome-
trium either breaks down or becomes transformed into the 
decidua of pregnancy.1 The fate of the endometrium depends 
foremost on implantation of an embryo capable of producing 
sufficient human chorionic gonadotropin (hCG), and other 
fitness hormones, to rescue the corpus luteum and maintain 
ovarian progesterone production.2 Although progesterone ex-
erts multiple functions, its primary role is to drive differen-
tiation of endometrial stromal cells (EnSC) into specialized 
decidual cells,1 which first encapsulate the implanting blas-
tocyst,3,4 and then form a robust immune-protective matrix to 
accommodate invading placental trophoblast.1,5
Recent studies demonstrated that decidualization is a 
multistep differentiation process that starts with an evolu-
tionarily conserved acute cellular stress response,6 exempli-
fied by a burst of free radicals, and release of inflammatory 
mediators.7,8 This inflammatory phase coincides with the 
implantation window,9,10 and is characterized further by the 
accumulation of proliferating uterine natural killer (uNK) 
cells.8 After a lag-period of approximately 4 days, phenotypic 
decidual cells emerge that are progesterone-dependent,11 
resistant to oxidative and metabolic stress,12,13 and highly 
responsive to embryonic signals.3,4,14 However, inflamma-
tory reprograming of EnSC also leads to the emergence of 
acute senescent cells.8,15 The topography of senescent decid-
ual cells, namely their proximity to the luminal epithelium, 
suggests that they arise from cells subjected to significant 
replication stress during the proliferative phase.15 Although 
morphologically similar to decidual cells, senescent decidual 
cells are progesterone-resistant and secrete an abundance of 
extracellular matrix (ECM) proteins and proteinases, pro-in-
flammatory cytokines, and chemokines (designated senes-
cence-associated secretory phenotype or SASP), which cause 
sterile inflammation and induce secondary senescence in 
neighboring decidual cells.8,15,16 Under continuous proges-
terone signaling in pregnancy, decidual cells secrete IL-15 
and other factors involved in recruitment and activation of 
uNK cells, which in turn target and eliminate senescent de-
cidual cells through perforin- and granzyme-containing gran-
ule exocytosis.8,15 In a non-conception cycle, however, falling 
progesterone in the late-luteal phase leads to a preponderance 
of senescent cells, influx of leukocytes, ECM breakdown, 
and menstrual shedding of the superficial uterine mucosa.17 
These novel insights into the cellular dynamics in the stroma 
during the window of implantation place uNK cells at the 
center of endometrial fate decisions.
Human preimplantation embryos are genetically di-
verse and prompt elimination of embryos of low-fitness is 
paramount to limit maternal investment in failing pregnan-
cies.18,19 Several studies have highlighted that decidual cells 
are programed to respond to embryos of different qual-
ity.3,4,14,20,21 Furthermore, growing evidence indicates that 
loss of this biosensing function of the endometrium causes 
recurrent pregnancy loss.18,22 Whether uNK cells are in-
volved in embryo selection at implantation is not known, 
although there is evidence that hCG stimulates uNK cell 
proliferation.23
Hyaluronan (HA), a ubiquitous ECM component, plays 
an important role in diverse biological processes that involve 
rapid tissue turnover and repair.24 Not surprisingly, HA has 
been implicated in key reproductive events, including ovula-
tion, fertilization, embryogenesis, implantation, and tropho-
blast invasion.25-27 HA, a linear glycosaminoglycan consisting 
of repeating disaccharide units of D-glucuronic acid and 
N-acetyl-D-glucosamine, is expressed in various molecular 
sizes up to 107 kDa.25 It is produced by three different hy-
aluronic acid-synthase enzymes (HAS1-3), each generating 
polymers of different lengths. Turnover of HA at tissue level 
is rapid, mediated by a family of hyaluronidases (HYALs). 
The biological actions of HA depend on its size and concen-
tration.24,25 High molecular weight HA (HMWHA) polymers 
are space-filling hydrating molecules that impede cell differ-
entiation and exert anti-angiogenic and immunosuppressive 
activities. Moreover, low molecular weight HA (LMWHA; 
molecular mass ≤ 250 kDa) activates a number of receptors, 
most prominently the cell-surface glycoprotein CD44 and 
hyaluronan-mediated mobility receptor (HMMR; otherwise 
known as RHAMM or CD168), involved in cell proliferation 
and migration, angiogenesis, and immunomodulation.24,25
In this study, we report that downregulation of HAS2 
expression upon decidualization of EnSC leads to loss of 
HA production. We exploited this observation to demon-
strate that exogenous HMWHA, but not LMWHA, abro-
gates uNK cell-mediated killing of senescent decidual 
cells. Furthermore, we show that human IVF blasto-
cysts of poorer morphological quality and those that 
failed to implant secrete lower levels of hyaluronidase 2 
(HYAL2) when compared to their successful counterparts. 
Importantly, the secretome of unsuccessful embryos also 
strongly inhibited uNK cell activity, an effect reversed by 
recombinant HYAL2. In contrast, we found no evidence 
that successful embryos impede uNK cell-mediated clear-
ance of senescence decidual cells.
2 |  MATERIALS AND METHODS
2.1 | Endometrial sample collection
The collection of endometrial biopsies for research pur-
poses was approved by the NHS National Research Ethics–
Hammersmith and Queen Charlotte’s & Chelsea Research 
Ethics Committee (REC reference: 1997/5065) and 
   | 3 of 15KONG et al.
Tommy’s National Reproductive Health Biobank (REC ref-
erence: 18/WA/0356). Endometrial biopsies were obtained 
using a Wallach Endocell endometrial sampler following 
transvaginal ultrasonography from patients attending a dedi-
cated research clinic at University Hospitals Coventry and 
Warwickshire (UHCW) National Health Service (NHS) 
Trust, Coventry, UK. Written informed consent was obtained 
prior to tissue collection in accordance with the guidelines of 
the Declaration of Helsinki, 2000. Endometrial biopsies were 
timed 5-10 days after the pre-ovulatory LH surge. A total of 
93 endometrial biopsies were processed for EnSC cultures, 
uNK cell isolation, or both. Demographic details of the tissue 
samples used in different experiments are shown in Table S1.
2.2 | Primary EnSC cultures
Human EnSC were isolated from endometrial biopsies as de-
scribed previously.28 Briefly, endometrial biopsies were sub-
jected to enzymatic digestion using 500 µg/mL of collagenase 
type Ia (Sigma-Aldrich, Poole, UK) and 100 µg/mL of DNase 
I (Lorne Laboratories Ltd, Reading, UK) for 1 hour at 37°C. 
Digested tissue was filtered through a 40 µM cell strainer 
to remove glandular cell clumps, and the flow-through col-
lected and cultured in DMEM/F12 (Thermo Scientific, 
Loughborough, UK) containing 10% dextran-coated char-
coal-treated fetal bovine serum (DCC-FBS), 1 × antibiotic-
antimycotic mix, 10 µM of L-glutamine (Thermo Scientific), 
1 nM of estradiol, and 2 μg/mL of insulin (Sigma-Aldrich). 
Cells were lifted with 0.05% trypsin and re-seeded as re-
quired. To induce decidual transformation, confluent EnSC 
monolayers were downregulated in phenol-free DMEM/F-12 
media containing 2% DCC-FBS and decidualized with 10 
µM of medroxyprogesterone acetate (MPA) and 0.5 mM 
of 8-bromo-cAMP (C+M treatment) (Sigma-Aldrich). To 
study the effect of exogenous HA, decidualizing EnSC were 
treated with either 100 µg/mL of HMWHA (molecular mass 
~1320 kDa) or LMWHA (molecular mass ~33.0 kDa), pur-
chased from Bio-Techne (USA), as described elsewhere.29,30 
Medium was refreshed every 2 days. All experiments were 
performed at passage 2.
2.3 | Isolation and culture of uNK cells
uNK cells were isolated and cultured as described in detail 
elsewhere.8,15 Briefly, unattached cells from freshly digested 
endometrial biopsies were collected following overnight cul-
ture, and red blood cells depleted via Ficoll-Paque density 
medium centrifugation (400 ×g) for 30 min at room tem-
perature (RT). uNK cells were isolated through magnetic-
activated cell sorting (MACS) using microbeads targeting 
CD56 (Miltenyi Biotec, Bergisch Gladbach, Germany, 
130-050-401), a specific marker for uNK cells. Cell density 
was adjusted to a maximum of 1 × 106 cells per 100 µL of 
wash buffer (0.5% BSA, 2 mM EDTA, and PBS) and incu-
bated for 15 minutes at 4°C with CD56 microbeads (1:20 di-
lution). Unbound microbeads were removed by addition of 
1 mL wash buffer, and cells were centrifuged (275 ×g) for 
5 minutes at RT and then, resuspended in 500 µL of wash 
buffer. Cells were fed through MS columns within a mag-
netic field wherein CD56+ cells were retained in columns 
and the negative fraction passed through. The MS columns 
were rinsed three times with 500 µL of wash buffer within 
the magnetic field before the CD56+ cells were extracted by 
flushing the column with 1 mL of wash buffer away from the 
magnetic field. Isolated uNK cells were cultured in DMEM/
F12 media supplemented with 10% of DCC-FBS, 1% of 
L-glutamine, and 1% of antibiotic/antimycotic, and contain-
ing 125 pg/mL of recombinant IL-15 (Sigma-Aldrich) to aid 
uNK cell maturation. uNK cells were cultured for no longer 
than 4 days.
2.4 | uNK-decidual co-culture assay
The uNK cells killing assay has been described in detail 
previously.8,15 Briefly, EnSC were seeded at a density of 
50  000 cells/well in 96-well plates and decidualized for 6 
days. Isolated uNK cells from whole endometrial tissue (n 
= 25 000) were then added to the cultures in the presence 
of C+M. Cultures continued for a further 2 days before har-
vesting for either RNA extraction or SA-β-Gal activity meas-
urement. For experiments investigating the expression of 
CLU and IL1RL1, experiments were scaled to 6-well plates. 
Conditioned media was collected prior to lysis of cells. To 
block CD44, isolated uNK cells were incubated with the 
CD44 neutralizing antibody Hermes-1 (Thermo Scientific, 
MA4400, 10 μg/ml, 30 min, RT) prior to co-culture assay. 
Where appropriate, 100 µg/mL of HMWHA or LMWHA 
(Bio-Techne, MN, USA) or BCM were added simultane-
ously with uNK cells at the indicated timepoints. When in-
dicated, HMWHA or BCM- was pre-incubated with 300 IU/
mL of recombinant HYAL2 (Sigma-Aldrich) for 30 minutes 
prior to the addition to co-cultures.
2.5 | Flow cytometry
The viability of isolated uNK cells was determined by in-
cubation with Fixable Viability Stain 660 (FVS660, BD 
Biosciences, NJ, USA) diluted 1:1000 in PBS for 10 minutes 
at 4°C. For analysis of purity, cell suspensions were incu-
bated with CD45-FITC (555482, 1:5, BD Bioscience) and 
CD56-PE (555516, 1:5, BD Bioscience) for 30 minutes in the 
dark at 4°C. After two washes with FACS buffer (0.5% BSA 
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and 2 mM EDTA in PBS), cells were resuspended in 500 µL 
of FACS buffer prior to analysis on BD FACSMelody flow 
cytometer.
2.6 | Immunocytochemistry of EnSC and 
uNK cells
Confluent EnSC monolayers were fixed with 4% paraform-
aldehyde for 5 minutes at RT and then, incubated with 1% 
BSA in PBS-T (PBS plus 0.1% Tween 20) for 30 minutes 
at RT. Cells were stained with biotin-labeled hyaluronic 
acid-binding protein (HABP) (AMSBIO, Abington, UK, 
AMS.HKD-BC41, 1:125) overnight at 4°C and stained with 
fluorescein-conjugated streptavidin (Vector Laboratories, 
Peterborough, UK, 1:500). Cells were counterstained with 
ProLong Gold Antifade Reagent with DAPI for nuclei stain-
ing (Cell Signaling Technology, MA, USA) before image 
capture with an EVOS FL Auto fluorescence microscope 
(Life Technologies, Paisley, UK). A total of three images 
were captured for each biological repeat experiment, using 
matched microscope and contrast/brightness settings and 
quantified by fluorescence intensity using ImageJ. HABP 
was expressed as a percentage of DAPI fluorescence to 
normalize for cell number in field of view. uNK cell cyto-
chemistry was performed with cytospin as described previ-
ously.8 Briefly, cell suspensions were loaded into EZ Single 
Cytofunnel (Thermo Scientific) and adhered to Surgipath 
X-tra microslides (Leica Biosystems, Wetzlar, Germany) by 
centrifugation (150 ×g) for 5 minutes at RT. Cells were fixed 
in 4% paraformaldehyde for 10 minutes, washed three times 
with wash buffer (0.05% Tween 20 in PBS) and blocked (1% 
BSA in PBS, 30 min, RT) to prevent nonspecific binding. 
Cells were incubated overnight at 4°C with antibodies di-
rected against CD44 (Thermo Scientific, MA4400; 1:200) 
and CD56 (Leica Biosystems, NCL-L-CD56-504; 1:100). 
Unbound primary antibody was removed by washing and 
cells stained for 1 hour at RT with Alexa Fluor 488 anti-rat 
secondary antibody (Thermo Scientific, A11006, 1:1000) for 
CD44 and Alexa Fluor 594 anti-mouse secondary antibody 
(Thermo Scientific; A21205, 1:1000) for CD56. Cells were 
counterstained with ProLong® Gold and viewed using an 
EVOS FL microscope.
2.7 | Reverse transcription quantitative 
PCR (RT-qPCR)
Total RNA from human EnSC was extracted using STAT-
60 (AMSBIO). Recovered RNA was quantified using a 
Nanodrop spectrophotometer and equal amounts of total 
RNA were transcribed into cDNA using the QuantiTect 
Reverse Transcription Kit (Qiagen, Manchester, UK). 
Analysis of target gene expression was performed through 
Power SYBR Green Master Mix (Life Technologies) on a 
7500 Real-Time PCR System (Applied Biosystems, CA, 
USA). The expression level of each gene was calculated 
using the ΔΔCt method and normalized against levels of the 
L19 housekeeping gene. Primer sequences used were as fol-
low: PRL sense 5′-AAG CTG TAG AGA TTG AGG AGC 
AAA C-3′,  PRL  antisense 5′-TCA GGA TGA ACC TGG 
CTG ACT A-3′,  IGFBP1  sense 5′-CGA AGG CTC TCC 
ATG TCA CCA-3′,  IGFBP1  antisense 5′-TGT CTC CTG 
TGC CTT GGC TAA AC-3′, IL1RL1 sense 5′-TTG TCC 
TAC CAT TGA CCT CTA CAA-3′, IL1RL1 antisense 5′-GAT 
CCT TGA AGA GCC TGA CAA-3′, CLU sense 5′-GGG ACC 
AGA CGG TCT CAG-3′, CLU antisense 5′-CGT ACT TAC 
TTC CCT GAT TGG AC-3′, L19 sense 5′-GCG GAA GGG 
TAC AGC CAA-3′, L19 antisense 5′-GCA GCC GGC GCA 
AA-3′, HAS2 sense 5′-GAT GCA TTG TGA GAG GTT 
TCT ATG-3′, HAS2 antisense 5′-GTA GCC AAC ATA TAT 
AAG CAG-3′, HYAL2 sense 5′-CAC AGT TCC TGA GCT 
GGT G-3′, HYAL2 antisense 5′-ACC AGG GCC AAT GTA 
ACG GT-3′.
2.8 | Enzyme-linked immunosorbent assay
Levels of secreted clusterin and sST2 in cell culture super-
natant were quantified using DuoSet Enzyme-linked im-
munosorbent assay (ELISA) kits (Biotechne, MN, USA). 
EnSC in 96-well plates were decidualized for 8 days, 
with spent media collected and refreshed every 2 days. 
Conditioned media was centrifuged (10 000 ×g) for 5 min-
utes at 4°C to remove cellular debris and stored at −20°C 
for assay. Quantitation of secreted factors proceeded ex-
actly as per manufacturer’s instructions with the absorb-
ance value determined on a PHERAstar FS plate reader 
(BMG Labtech, Ortenberg, Germany) at 450 nm. Samples 
were interpolated from known standards using a four pa-
rameter logistics fit.
2.9 | SA-β-Gal quantitation
Levels of cellular SA-β-Gal were determined using the 96-
well Quantitative Cellular Senescence Assay kit (Cell Biolabs 
Inc; CA, USA), using a modified version of the manufac-
turer’s protocol. Decidualizing EnSC in 96-well plates were 
washed with ice-cold PBS and lysed in 50 μL of ice-cold 
assay lysis buffer containing protease inhibitors (cOmplete 
Protease Inhibitor Cocktail, Roche). Lysates (25 µL) were 
transferred to black-walled, black-bottomed 96-well plates, 
and 25 µL of 2× assay buffer was added. Plates were sealed 
and the reaction was incubated for 1 hour at 37°C in a non-
humidified, non-CO2 incubator. The reaction was terminated 
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by the addition of 200 μL stop solution and fluorescent inten-
sity unit (FIU) determined on a PHERAstar FS plate reader 
(BMG Labtech) at 360/465 nm. Assays were normalized to 
seeding density.
2.10 | Collection of blastocyst 
conditioned media
Blastocyst conditioned media (BCM) from IVF embryos cul-
tured in individual droplets were obtained from two different 
units: Centre for Reproductive Medicine, UHCW NHS Trust, 
and Eugin Clinic, Barcelona, Spain. Following embryo trans-
fer, BCM obtained from embryos that resulted in a positive 
or negative pregnancy test were designated positive (BCM+) 
or negative (BCM−), respectively. Parallel droplets without 
embryos were also obtained and designated unconditioned 
media (UCM).
Collection of BCM at UHCW NHS Trust was approved 
by the Research Ethics Committee West Midlands, Coventry 
and Warwickshire (REC Reference: 12/WM/0094). 
Fertilized zygotes were cultured in Cleav medium (Origio, 
Denmark) for 3 days, followed by Blast medium (Origio) 
for culture to the blastocyst stage. Cultures were performed 
in an atmosphere of 6% CO2, 5% O2, and 89% N2, in an 
Embryoscope time-lapse incubator, with each embryo in an 
individual well containing 25 µL of culture medium under 
mineral oil. Embryo transfer was performed on day 5 after 
egg collection with the medium frozen in situ the following 
day and stored at −80°C until use.
Collection of BCM at Eugin Clinic, Barcelona, was 
approved by the Comite de Etica de la Investigación 
con Medicamentos (CEUGIN-2019-08-KILLDROP) on 
22/10/2019. Embryos were cultured in SAGE 1-Step media 
(CooperSurgical, Denmark) covered with Ovoil (Vitrolife, 
Sweden). Cultures were performed in conventional incuba-
tors at 37°C under an atmosphere of 6% CO2, 5% O2, and 
89% N2. BCM (10 µL) was collected after embryo transfer 
on day 5 and transferred from the culture plate to a 0.6 mL 
Eppendorf tube. Drops were collected individually. In the 
same way, UCM were collected from the sample plate. BCM 
and UCM were stored at −80°C until use. At both centers, the 
collection of BCM was fully anonymized in accordance with 
the approvals of the respective Ethics Committees.
2.11 | HYAL2 expression and secretion in 
human embryos
The research use of human cryopreserved embryos that 
were surplus to patient requirements was approved by the 
Research Ethics Committee, Coventry and Warwickshire 
(REC Reference: 04/Q2802/26), and the Human Fertilisation 
and Embryology Authority (Reference: R0155). All patients 
provided informed written consent. To examine the expres-
sion of HYAL2, vitrified human blastocysts were warmed 
using the Vit Kit thawing protocol according to the manufac-
turer’s instructions (Irvine Scientific, Co. Wicklow, Ireland). 
Blastocysts were transferred to PBS solution and fixed in 2% 
PFA, 4% BSA in PBS solution at RT for 2 hours. Where ap-
propriate, the zona pellucida was removed by brief incubation 
in acid Tyrode’s solution prior to fixation. Fixed blastocysts 
were washed in 4% BSA in PBS before permeabilization in 
0.5% Triton X-100 in PBS at RT for 2 hours and then, washed 
in 0.2% Tween 20 in PBS for 15 minutes. Nonspecific anti-
body-binding sites were blocked with blocking solution (4% 
BSA, 5% goat serum, and 0.2% Tween 20 in PBS) at RT for 1 
hour. Immuno-detection proceeded by overnight incubation 
of rabbit anti-HYAL2 primary antibody (Abcam, ab68608, 
1:100) in blocking solution at 4°C. Unbound primary anti-
body was removed the following day by washing in 0.2% 
Tween 20 in PBS and blastocysts incubated for 2 hours at RT 
with goat anti-rabbit Alexa Fluor 488-conjugated secondary 
antibodies (Abcam, ab150077). Following washing, blasto-
cysts were transferred to 5 µL Vectashield mounting medium 
containing DAPI on a glass slide. To protect the 3D integrity 
of the blastocyst, a small pinhead-sized drop of paraffin wax 
was placed in each corner of a 10 × 10 mm coverslips be-
fore setting over the sample. HYAL2 immunofluorescence 
in blastocysts was viewed on an Olympus 1X81 microscope 
using 490 nm excitation and 525 nm emission wavelengths. 
DAPI was detected at 359/461 nm.
To measure secreted HYAL2 levels, embryo conditioned 
media was diluted 1:10 with blast™ medium (Origio) with 
HYAL2 levels quantified by ELISA as per the manufactur-
er’s protocols (ABIN841408, Antibodies Online). Additional 
information on these embryos is presented in Table S2. 
Morphological assessment of embryos was based on stan-
dardized criteria.31 Briefly, the inner cell mass and trophecto-
derm of embryos were assessed morphologically and graded 
separately on a scale of A-E, with A being the best and E the 
worst.31 Blastocysts graded <BB were deemed low quality.
2.12 | Statistical analysis
Because of intrinsic variability between primary cultures, the 
data are presented as fold-change relative to an informative 
comparator and analyzed using paired one-way ANOVA with 
a Dunnett’s multiple comparison test. Normal distribution was 
confirmed by the Shapiro-Wilk test of normality. The level of 
embryonic HYAL2 secretion between groups was compared 
using an unpaired t test. Individual data points are shown for 
biological replicates and repeat experiments. P < .05 was con-
sidered significant with different letters above the bar graphs 
indicating significant differences between groups
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3 |  RESULTS
3.1 | Loss of HA synthesis upon 
decidualization of EnSC
We examined HA expression in decidualizing primary EnSC 
cultures using biotin-labeled hyaluronic acid-binding protein 
(HABP).32 HABP reactivity was prominent in undifferenti-
ated EnSC but downregulated upon decidualization with 
8-bromo-cAMP and the progestin medroxyprogesterone 
(C+M) (Figure 1A). Quantitative analysis confirmed that 
HA reactivity declines by 74% and 94%, respectively, after 
4 and 8 days of decidualization (Figure 1B). To explore the 
mechanisms accounting for the loss of HA production upon 
decidualization, we examined the expression of the three hya-
luronic synthases (HAS1-3) and five catabolic hyaluronidases 
[HYAL1-4 and sperm adhesion molecule 1 (SPAM1)].25,33,34 
First, we mined publicly available RNA-seq data of undif-
ferentiated EnSC and cells decidualized for 4 days (GEO 
accession number: GSE104721). HAS1, HAS3, HYAL1, and 
HYAL4 mRNA levels were generally below three transcripts 
per million (TPM) in both undifferentiated and decidualized 
cells, suggesting little or no expression (Figure S1). SPAM1, 
a testis-specific gene,35 is not expressed by EnSC and HYAL3 
does not encode for a classical hyaluronidase, although it may 
play a role in augmenting HYAL1 activity.36,37 In contrast, 
the average (± SEM) expression of HAS2 and HYAL2 in un-
differentiated EnSC was 20.5 (± 11.4) and 48.0 (± 4.3) TPM, 
respectively. Upon decidualization, HAS2 was downregu-
lated, whereas HYAL2 transcript levels remained unchanged 
(Figuire S1). To confirm these observations, HAS2 and 
HYAL2 mRNA levels were measured by RT-qPCR in five 
independent primary EnSC cultures decidualized for 4 or 8 
days. In agreement with the RNA-seq data, HYAL2 expres-
sion was maintained throughout the decidual time-course, 
whereas HAS2 mRNA levels declined by 56% and 82% after 
4 and 8 days of decidualization, respectively (Figure 1C; P 
< .005, Dunnett’s multiple comparisons test).
We postulated that loss of endogenous HA production 
may render decidualizing cells responsive to HA derived 
from other sources, for example the implanting blastocyst.38 
To test this hypothesis, three independent primary EnSC 
cultures were first decidualized for 4 days to downregulate 
endogenous HA production and then, decidualized for four 
additional days in the presence or absence of LMWHA or 
HMWHA (Figure 1D). As shown in Figure 1E, HA had no 
effect on the induction of the canonical decidual marker 
genes PRL and IGFBP1, irrespective of its molecular weight. 
Expression of CLU and IL1RL1, marker genes of senescent 
decidual cells and decidual cells, respectively,15 were also not 
affected by HA. CLU codes the secreted molecular chaperone 
clusterin (also known as apolipoprotein J), whereas both the 
transmembrane and soluble IL-33 receptors (termed ST2L 
and sST2, respectively), are encoded by IL1RL1. In keeping 
with the observations at transcript level, we found no evi-
dence that HA impacted on either clusterin or sST2 secretion 
in decidualizing cells (Figure 1F). To confirm that HA does 
not affect decidual subpopulations, senescence-associated 
β-galactosidase (SA-β-Gal) activity was measured in parallel 
cultures. As expected, decidualization was associated with a 
robust increase in SA-β-Gal activity but addition of HA had 
no effect on basal or induced levels (Figure 1G).
3.2 | HMWHA inhibits uNK cell 
clearance of senescent decidual cells
To explore if there is a role for HA signaling in the peri-
implantation endometrium, we examined the expression of 
putative HA receptors using recently generated single-cell 
RNA-seq data from endometrial biopsies obtained 8 and 10 
days following the pre-ovulation LH surge (GEO accession 
number: GSE127918).15 Several genes coding HA recep-
tors were expressed prominently in endometrial endothelial 
cells (Figure 2A), including ICAM1 (coding intercellu-
lar adhesion molecule 1), LAYN (layinin) and TLR4 (toll-
like receptor 4), pointing toward a potential role for HA 
signaling in vascular remodeling in pregnancy. The most 
striking observation, however, was the high expression 
of CD44, the principal HA receptor, in uNK cells (Figure 
2A). CD44 regulates cytotoxicity of circulating NK cells 
and potentially their trafficking to the endometrium.39,40 
These observations prompted us to investigate if HA-CD44 
interactions modulate uNK cell-dependent clearance of se-
nescent decidual cells. To test our hypothesis, uNK cells 
were isolated from midluteal endometrial biopsies using 
magnetic-activated cell sorting (MACS). Flow cytometry 
analysis of uNK cells isolated from three independent biop-
sies showed an average viability (± SEM) of 80.8% (± 2.5) 
(Figure 2B). Furthermore, 95% (± 1.4) of CD56+ cells co-
expressed the pan-leukocyte marker CD45 (Figure 2C) and 
79.7% (± 1.9) the canonical HA receptor CD44 (Figure 2D). 
Expression of CD44 on CD56+ uNK cells was confirmed 
by immunocytochemistry (Figure 2E). To validate that uNK 
cells selectively target senescent decidual cells, co-cultures 
were established with EnSC first decidualized for 6 days. 
After 48 hours, the co-cultures were processed for SA-β-Gal 
activity measurement or RNA extraction (Figure 2F). Spent 
medium was also collected and secreted clusterin and sST2 
levels measured by ELISA. As expected, the induction of 
SA-β-Gal activity upon decidualization was abrogated in 
the presence of uNK cells, as was the induction and secre-
tion of clusterin (Figure 2H). In contrast, IL1RL1 mRNA 
expression and sST2 levels were unaffected (Figure 2I), 
confirming that uNK cells selectively target and eliminate 
senescent decidual cells.
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Next, we treated seven independent decidual-uNK cell 
co-cultures with either HMWHA or LMWHA. As shown 
in Figure 3A, HMWHA inhibited uNK cell-mediated clear-
ance of senescent decidual cells, exemplified by the lack of 
downregulation of SA-β-Gal activity and clusterin secretion. 
sST2 secretion was unaffected by HMWHA. Furthermore, 
addition of LMWHA had no effect on either SA-β-Gal ac-
tivity or clusterin and sST2 secretion in decidual-uNK cell 
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F I G U R E  2  Decidual-uNK cell co-cultures. A, Heatmap showing relative expression of genes coding putative HA receptors in different 
endometrial cell types in vivo. EC, endothelial cells; EnEC, endometrial epithelial cells. B-D, Flow cytometric analysis. B, Viability of uNK cells 
following MACS isolation was determined by FV660 exclusion. C, Purity of uNK cells after MACS isolation was determined by gating cells for 
CD56 and CD45. D, Histogram depicting CD56+/CD44+ uNK cells after MACS isolation (filledhistogram) vs negative control (openhistogram). 
Representative dot plots or histogram are shown together with bar graphs (mean ± SEM) showing individual data points of three biological repeat 
experiments. E, Cytospin preparations of isolated uNK cells stained for DAPI (nucleus), CD56 and CD44. Co-localization of CD56 and CD44 is 
shown in bottom right panel. Scale = 100 µM. F, Schematic representation of the decidual-uNK cell co-culture killing assay. G-I, Analysis of SA-
β-Gal activity (G), senescent decidual cell markers (H), and decidual markers (I) in decidualizing EnSC co-cultured with or without uNK cells. The 
data show relative change to the indicated measurements in three biological repeat experiments compared to cultures decidualized with C+M for 
8 days in the absence of uNK cells. Different letters above the bar graphs (mean ± SEM) indicate statistical differences (P < .05) between groups 
(one-way ANOVA and Dunnett’s multiple comparison test)
F I G U R E  1  Loss of HA production upon decidualization. A, Representative images of HABP immunofluorescence in undifferentiated 
EnSC (day 0) and cells decidualized with 8-br-cAMP and MPA (C+M) for 4 or 8 days. Scale = 200 µM, insert = 50 µM. Cultures treated with 
recombinant HYAL2 to digest HA were used as control (insert, upperpanel). B, Quantification of HABP+ cells. The data show the relative change 
in HABP+ cells (mean ± SEM) upon decidualization in four independent primary cultures. ** indicates P < .01 and ***P < .001, ANOVA 
with Dunnett’s multiple comparison test. C, RT-qPCR analysis of HYAL2 mRNA (left panel) and HAS2 mRNA (right panel) expression in 
undifferentiated EnSC (day 0) and cells decidualized for 4 or 8 days. The data show the relative change in transcript levels (mean ± SEM) upon 
decidualization of five independent primary cultures at the indicated timepoints. * denotes P < .05 and **P < .01, ANOVA and Dunnett’s multiple 
comparison test. D, Experimental design of decidualizing EnSC treated with HA. E-G, HMWHA and LMWHA do not impact decidual marker 
gene expression (E), clusterin and sST2 secretion (F), or SA-β-Gal activity (G). Individual data points from three biological repeat experiments are 
shown together with bar graphs denoting mean ± SEM. Different letters indicate significance between groups at P < .05 (one-way ANOVA and 
Dunnett’s multiple comparison test)
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F I G U R E  3  HMWHA inhibits uNK cell-dependent killing of senescent decidual cells. A, Impact of HMWHA and LMWHA on uNK 
cell-dependent killing of senescent decidual cells in seven biological repeat experiments. Killing of senescent decidual cells was monitored by 
SA-β-Gal activity and secreted clusterin levels. sST2 is selectively secreted by decidual cells. B, Impact of HMWHA or HMWHA pre-incubated 
with HYAL2 on uNK cell-dependent killing of senescent decidual cells in six biological repeat experiments. C, Impact of CD44 inhibition using a 
monoclonal antibody (CD44 mAb) on uNK cell-dependent killing of senescent decidual cells in the presence or absence of HMWHA or LMWHA 
in four biological repeat experiments. The data show relative change in the indicated measurements compared to cultures decidualized for 8 days in 
the absence of uNK cells. Different letters above the bar graphs (mean ± SEM) indicate statistical differences (P < .05) between groups (one-way 
ANOVA and Dunnett’s multiple comparison test)
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co-cultures. To substantiate these observations, six additional 
co-cultures were established and treated with either HMWHA 
or HMWHA pre-incubated with recombinant HYLA2, the 
enzyme that selectively degrades HMWHA into smaller frag-
ments.41 As demonstrated in Figure 3B, HMWHA inhibition 
of uNK cell-dependent clearance of senescent decidual cell 
markers, monitored by SA-β-Gal activity and clusterin secre-
tion, was completely lost upon pre-incubation with recombi-
nant HYLA2. Addition of HYAL2 alone to the co-cultures had 
no effect on uNK-dependent clearance of senescent decidual 
cells (Figure 3B). Degradation of HA by HYAL2 into smaller 
fragments initiates CD44 cell signaling.24,25,42 To explore 
the role of CD44, co-cultures were treated with Hermes-1, 
a monoclonal antibody that recognizes the N-terminal HA-
binding domain of CD44.43 Incubation of co-cultures with 
this blocking antibody inhibited uNK cell-mediated clear-
ance of senescent decidual cells (Figure 3C), irrespective of 
treatment with LMWHA or HMWHA. Taken together, the 
data indicate that HMWHA is a potent inhibitor of uNK cell 
activation, an effect that likely involves silencing of CD44 
signaling.
3.3 | uNK cells are biosensors of embryo 
quality at implantation
The HA system is tightly controlled in preimplantation em-
bryos and trophoblast cells.25,27 We speculated that embryo-
derived HA signaling may determine endometrial responses 
at the implantation site by modulating uNK cell activity. To 
investigate this possibility, we adapted our co-culture sys-
tem as depicted in Figure 4A. Briefly, in two different IVF 
centers, blastocyst conditioned medium (BCM) was pooled 
from individual fully anonymized day-5 IVF embryos, which 
resulted either in an ongoing pregnancy following single-
embryo transfer (BCM+, ie, positive pregnancy test 15 days 
after embryo transfer; n = 28) or failed implantation (BCM−, 
negative pregnancy test; n = 38). Each pool consisted of 80 
µL of spent media recovered from seven blastocysts. We also 
collected UCM from parallel embryo-free droplets. Next, 
we decidualized nine independent primary EnSC cultures 
for 6 days and then co-cultured uNK cells in UCM, BCM+ 
or BCM− diluted 1 in 7.5 with decidualization medium. 
Co-cultures were harvested after 48 hours. Strikingly, uNK 
cell-mediated killing of senescent decidual cells, as meas-
ured by SA-β-Gal activity and secreted clusterin levels, was 
unaffected by UCM or BCM+ but markedly inhibited in re-
sponse to soluble signals emanating from unsuccessful blas-
tocysts (BCM−) (Figure 4B). Pre-incubation of BCM− with 
recombinant HYLA2 fully restored uNK cell activity against 
senescent decidual cells (Figure 4C). Notably, exposure of 
decidualizing EnSC to either UCM, BCM+ or BCM− had 
no effect on either SA-β-Gal activity or clusterin and sST2 
secretion in the absence of co-cultured uNK cells (Figure S2). 
Taken together, the data strongly infer a central role for uNK 
cells in embryo recognition and selection upon implantation. 
Furthermore, the level of embryo-derived HYAL2 secretion 
appears to determine uNK cell activity.
Expression of HYAL2 in human blastocysts was con-
firmed by immunocytochemistry (Figure 4D). We also 
collected BCM from 43 human IVF embryos transferred 
on day 5 and quantified HYAL2 levels by ELISA in indi-
vidual droplets (Table S2). As shown in Figure 4E, human 
embryos deemed of low-quality based on morphological cri-
teria,31 secreted lower levels of HYAL2 when compared to 
good-quality (grade: ≥BB) embryos (P =  .003, unpaired t 
test). Similarly, embryos that implanted successfully follow-
ing transfer secreted higher levels of HYAL2 when compared 
to their unsuccessful counterparts (P = .042, unpaired t test; 
Figure 4F).
Taken together, our results implicate uNK cells as pivotal 
biosensors of embryo quality and identified the level of em-
bryo-derived HYAL2 secretion as a major determinant for 
successful implantation. Figure 5 summarizes the proposed 
mechanism of embryo-dependent modulation of uNK cell ac-
tivity in endometrial fate decisions at implantation.
4 |  DISCUSSION
Based on sensitive urinary hCG measurements, several pro-
spective observational studies reported miscarriage rates of 
approximately 30% in young women trying to conceive.44-47 
Most of these losses involve menstruation-like shedding of 
the endometrium 1-2 weeks after implantation and are, there-
fore, often not recognized clinically. The high attrition rate 
in the very early stages of pregnancy is widely attributed to 
embryonic aneuploidy, caused either by age-dependent mei-
otic errors in oocytes or age-independent erroneous mitotic 
divisions during preimplantation development.48,49 A recent 
analysis of published single-cell RNA-seq data concluded 
that 80% of human embryos harbor aneuploid cells.50 This 
intrinsic genetic instability of human embryos, which gives 
rise to a vast array of chromosomal errors, poses a major 
challenge to the endometrium; how to eliminate embryos 
of low-fitness without compromising implantation of high-
quality embryos?
Evidence from multiple mammalian species indicates that 
the endometrium is capable of mounting an implantation 
response tailored to the developmental potential of individ-
ual embryos.21,51-53 In humans, directed migration of decid-
ualizing EnSC and active encapsulation of the conceptus 
constitutes an important initial step in the implantation pro-
cess.52 In vitro studies demonstrated that high-quality human 
embryos stimulate migration of decidual cells, whereas 
low-quality embryos fail to do so. Conversely, migration of 
   | 11 of 15KONG et al.
undifferentiated EnSC is actively inhibited by high-quality 
embryos, but not low-quality embryos.3,4,20,54 Furthermore, 
cross-species experiments demonstrated that flushing of the 
mouse uterus with spent culture medium from human IVF 
embryos deemed of insufficient quality for transfer triggers 
an acute cellular stress response; whereas uterine flushing 
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with spent medium of successfully implanted human em-
bryos (ie, resulting in ongoing pregnancies) enhances endo-
metrial expression of multiple metabolic and implantation 
genes.21 These observations indicate that human embryos are 
subjected to both negative and positive selection at implan-
tation.22 The nature of embryonic “quality” signals decoded 
by decidual cells is largely unknown, although recent studies 
have provided some insights. For example, compelling exper-
imental evidence implicated embryo-derived microRNAs, 
more specifically hsa-miR-320a, in stimulating directional 
migration of decidualizing EnSC.20 Interestingly, hsa-miR-
320a also acts in an autocrine manner to promote develop-
ment of preimplantation embryos.55 Moreover, heightened 
secretion of tryptic serine proteinases by low-quality em-
bryos, perhaps reflecting proteotoxic stress induced by aneu-
ploidy, induces endoplasmic reticulum stress in decidualizing 
EnSC,21 with loss of secretion of pro-implantation modula-
tors such as LIF, IL-1β, and HB-EGF.14
Despite these emerging insights, it remains unclear 
how a local embryo-induced endometrial stress response 
triggers a concatenation of events that ultimately leads to 
breakdown of the entire superficial endometrium, even in 
women receiving progesterone supplements. Several lines 
of evidence indicate that endometrial fate decisions at im-
plantation pivot on the surveillance and clearance of senes-
cent decidual cells by uNK cells. First, senescent decidual 
cells are progesterone-resistant and produce a cocktail of 
factors involved in ECM remodeling, including multiple 
proteases, and inflammation.15 Second, unlike undifferen-
tiated EnSC, decidual cells are highly susceptible to sec-
ondary senescence (also termed “bystander” senescence), 
enabling rapid propagation of the senescent phenotype 
throughout the tissue.8,15 We further demonstrated that 
recurrent pregnancy loss is associated with a pro-senes-
cence decidual response in non-conception cycles, linked 
to loss of clonogenic progenitor cells and uNK cell defi-
ciency.15,56-58 Here, we show that uNK cell-dependent 
clearance of senescent decidual cells is actively suppressed 
by low-fitness embryos, which is predicted to promulgate 
secondary senescence and lead to tissue breakdown. We 
F I G U R E  4  uNK cells are biosensors of low-fitness human embryos. A, Schematic depiction of experimental design. BCM, blastocyst 
conditioned medium; UCM, unconditioned medium; and PT, pregnancy test. B, Impact of UCM, BCM+, and BCM- on uNK cell-dependent killing 
of senescent decidual cells in nine biological repeat experiments. Killing of senescent decidual cells was monitored by SA-β-Gal activity and 
secreted clusterin levels. sST2 is selectively secreted by decidual cells. C, Impact of BCM- or BCM- pre-incubated with HYAL2 on uNK cell-
dependent killing of senescent decidual cells in four biological repeat experiments. The data show relative change in the indicated measurements 
compared to decidual-uNK cell co-cultures exposed to UCM. Different letters above the bar graphs (mean ± SEM) indicate statistical differences 
(P < .05) between groups (one-way ANOVA and Dunnett’s multiple comparison test). D, HYAL2 immuno-reactivity in unhatched and hatched 
human blastocysts (left and right panels, respectively). Scale = 100 µM. E, secreted HYAL2 levels in conditioned media from embryos graded 
morphologically as good (grade ≥BB) or poor (<BB). F, Secreted HYAL2 levels in culture medium conditioned by embryos that either resulted in 
a positive or negative pregnancy test following single-embryo transfer. * indicates P < .05, ** indicates P < .01 (unpaired t test)
F I G U R E  5  Schematic summary of the role of uNK cell sensing of embryos in endometrial fate decisions at implantation. For detailed 
explanation, see text
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also demonstrate that HYAL2 restores killing of senescent 
decidual cells in the presence of cues from low-quality em-
bryos. Combined with other lines of evidence presented 
in this study, this observation firmly implicate HMWHA-
silencing of CD44 activity in abrogating uNK cell cyto-
toxicity. Indeed, HMWHA possesses multivalent sites to 
bind CD44, promotes clustering of the receptor, and inhib-
its downstream pathways, including Rac-dependent sig-
naling.24 Interestingly, both HA production and HYAL2 
expression have been shown to be critical for embryo de-
velopment in animal studies.25 For example, inhibition of 
HA synthesis by 4-methyumbelliferone suppresses bovine 
blastocyst formation,59 whereas HA supplementation of 
culture media improves embryo development in multiple 
species.25 The effects of HA on embryo development are 
dependent on HYAL2 as LMWHA promotes development, 
whereas HMWHA exerts the opposite effect.60 HYAL2 
transcripts are constitutively expressed in human preim-
plantation embryos.26 Here, we showed by immunocyto-
chemistry that this glycosylphosphatidylinositol-anchored 
enzyme localizes to both the trophectoderm and inner cell 
mass of human blastocysts. Importantly, HYAL2 was also 
detectable in BCM, with levels correlating to both embryo 
morphology and implantation competence. Thus, as re-
ported for hsa-miR-320a,20 embryonic HYAL2 expression 
appears critical for both preimplantation development and 
endometrial responses upon implantation.
Increased deposition of HA into the ECM, specifically 
LMWHA, is a hallmark of inflammatory processes.24 In 
the postovulatory endometrium, HA deposition first peaks 
during the midluteal window of implantation but then de-
clines rapidly in the stroma.61 These observations are 
congruent with the decline in HA production in EnSC de-
cidualized in vitro for 4 days or longer. Furthermore, loss of 
HA expression in decidual cells surrounding the conceptus 
has also been reported in mice.62 Although we demonstrated 
that HA production declines in parallel with transcriptional 
silencing of HAS2, decidualization is also associated with 
loss of O-linked N-acetylglucosamine (GlcNAc) transferase 
(OGT),13 an enzyme that strongly increases HAS2 activ-
ity and stability through O-GlcNAcylation of serine 221.63 
Despite the lack of HA, uNK cell-dependent killing of senes-
cent decidual cells was attenuated upon CD44 inhibition and 
addition of LMWHA did not enhance uNK cell cytotoxicity 
in co-cultures. These observations suggest that decidual cells 
either continue to produce low levels of HA fragments or ex-
press alternative CD44 ligands. Two plausible candidates are 
osteopontin and serglycin,64 both of which are strongly up-
regulated upon decidualization, at least at transcript level.15
In summary, we report for the first time that uNK cells are 
biosensors of low-fitness human embryos. We demonstrated 
that the embryo-sensing function of uNK cells relates to 
HYAL2 expression in the blastocyst and its ability to degrade 
HMWHA. Furthermore, the role of uNK cells in embryo se-
lection at implantation may depend on an adequate decidual 
response, creating a permissive local environment devoid of 
HMWHA production. We posit that loss of uNK cell activity 
at the implantation site propagates decidual senescence and 
facilitates menstruation-like shedding of the endometrium.
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